Table 2. Cohort characteristics of studies included in the meta-analysis (alphabetically list).
| Author & Year | Gender | Age | Mean stroke duration(year) | Lesion type | Side affected | Baseline of FMA-UE |
|---|---|---|---|---|---|---|
| Brunner 2012 [53] | BULT:8/8; UULT:3/11 | BULT:64.8±12.8; UULT:61.0±10.0 | BULT:0.1±0.1; UULT:0.1 ±0.1 | BULT:4/12; UULT:1/13 | BULT:4/12; UULT:1/13 | Not Reported |
| Desrosier 2005 [54] | BULT:11/9; UULT:11/10 | BULT:72.2±10.8;UULT:74.3±10.1 | BULT:0.09±0.09;UULT:0.10±0.09 | BULT:1/19; UULT:0/21 | BULT:13/7; UULT:10/11 | BULT: 42.90±20.00; UULT: 47.00±16.10 |
| Han 2016 [15] | BULT:8/5; UULT:9/3 | BULT:78.8; UULT:72.9 | BULT:6.92; UULT:6.48 | Not Report | BULT:13/0; UULT:12/0 | Not Reported |
| Hsieh 2017 [46] | BULT:5/11; UULT:8/7 | BULT:49.28±10.90; UULT:52.87±10.40 | BULT:0.21±0.14; UULT:0.18 ±0.09 | BULT:8/8; UULT:8/7 | BULT:8/8; UULT:4/11 | BULT: 26.81±12.13; UULT: 29.07±16.12 |
| Kim 2013 [20] | Not Reported | Not Reported | Not Reported | Not Reported | BULT:1/4; UULT:2/3 | BULT: 24.4±5.2; UULT: 23.8±7.7 |
| Lee 2017 [27] | BULT:6/9; UULT:5/10 | BULT:57.33± 9.88; UULT: 54.60 ± 16.03 | Not Reported | BULT:7/8; UULT:9/6 | BULT:5/10; UULT:6/9 | BULT: 48.73±16.42; UULT: 46.60±12.03 |
| Liao 2012 [22] | BULT:4/6; UULT:3/7 | BULT:55.51±11.17; UULT:54.56±8.20 | BULT:1.99±1.12; UULT:1.09±0.68 | Not Reported | BULT:4/6; UULT:3/7 | BULT: 44.90±9.02; UULT: 39.60±11.27 |
| Lin 2010 [18] | BULT:6/10; UULT:8/9 | BULT:52.08± 9.60; UULT:55.50±13.17 | BULT:1.16±1.06; UULT:1.09±1.1 | Not Reported | BULT:9/7, UULT:8/9 | BULT: 45.50±10.35; UULT: 49.75±12.10 |
| Lin 2015 [19] | BULT:4/12; UULT:0/17 | BULT:52.63±10.49; UULT: 57.47±10.29 | BULT:2.31±1.59; UULT:1.82±1.81 | BULT:9/7; UULT:6/11 | BULT:4/12; UULT:0/17 | BULT: 35.69±15.56; UULT: 38.71±19.98 |
| Luft 2004 [23] | BULT:2/7; UULT:7/5 | BULT:63.3±15.3; UULT:59.6±10.5 | BULT:6.25; UULT:3.79 | BULT:9/0; UULT:12/0 | BULT:3/6; UULT:4/8 | BULT: 29.60±12.25; UULT:28.30 ±4.41 |
| Lum 2006 [26] | BULT:3/2; UULT:2/4 | BULT:72.2±11.7; UULT:59.9±5.5 | BULT:0.12±0.02; UULT:0.20±0.05 | Not Reported | BULT:2/3; UULT:2/4 | BULT: 39.20±4.30; UULT: 26.00±3.30 |
| Meng 2017 [21] | BULT:30/34; UULT:33/31 | BULT:55.38±6.97; UULT:55.19±7.82 | BULT:8.87±2.69h; UULT:9.08±2.35h | BULT:14/50; UULT:19/45 | BULT:29/35; UULT:31/33 | BULT: 33.25±5.89; UULT: 32.86±5.11 |
| Morris 2008 [17] | BULT:22/34; UULT:23/27 | BULT:67.9±13.1; UULT:67.8±9.9 | BULT:0.06±0.02; UULT:0.06±0.02 | BULT:53/3; UULT: 44/6 | BULT:27/29; UULT:27/23 | Not Reported |
| Shahine 2014 [58] | BULT:19/21; UULT:17/19 | BULT:61.4±5.5; UULT:62.7±3.1 | BULT:2.6±1.8; UULT:3.0±1.6 | Not Reported | BULT:23/17; UULT:21/15 | BULT: 40.50±6.20; UULT: 38.50±6.10 |
| Singer 2013 [57] | BULT:4/6; UULT:2/8 | BULT:68.6±9; UULT: 68±16.4 | BULT:4.33±4.02; UULT:5.33±4.12 | Not Reported | BULT:5/6; UULT:5/5 | BULT: 38.00±9.60; UULT: 30.50±12.80 |
| van Delden 2013 [28] | BULT:8/11; UULT:3/16 | BULT:62.6±9.8; UULT:56.9±12.7 | BULT:7.8±4.9; UULT:11.1±6.8 | Not Reported | BULT:11/8; UULT:11/8 | BULT: 42.70±12.40; UULT: 39.00±10.30 |
| Waller 2008 [56] | BULT:4/5; UULT:7/2 | BULT:58.0±12.4; UULT:54.1±8.6 | BULT:6.1±5.8; UULT:2.6±1.8 | Not Reported | BULT:5/4; UULT:5/4 | BULT: 35.22±12.30; UULT: 34.00±13.20 |
| Whitall 2011 [25] | BULT:16/26; UULT:26/24 | BULT:59.8±9.9; UULT:57.7±12.5 | BULT:4.5±4.1; UULT:4.1±5.2 | Not Reported | BULT:18/23; UULT:25/25 | BULT: 32.30±2.20; UULT: 31.00±2.10 |
| Wu 2011 [16] | BULT:4/18; UULT:6/16 | BULT:52.22±10.72; UULT:55.19±2.50 | BULT:1.33±1.15; UULT:1.48±1.04 | Not Reported | BULT:10/12; UULT:12/10 | Not Reported |
| Wu 2013 [24] | BULT:5/13; UULT:5/12 | BULT:52.21±12.2; UULT:54.22±9.78 | BULT:1.94±1.28; UULT:1.95±1.27 | Not Reported | BULT:9/9; UULT:9/8 | Not Reported |
| Yang 2012 [55] | BULT:3/4; UULT:2/5 | BULT:51.4±10.9; UULT:50.8±6.1 | BULT:1.23±0.48; UULT: 1.03±0.37 | Not Reported | BULT:4/3; UULT:4/3 | BULT: 41.90±3.90; UULT: 40.90±6.40 |
BULT, Bilateral Upper Limb Training; UULT, Unilateral Upper Limb Training; FMA-UE, Fugl-Meyer Assessment of Upper Extremity